J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dasgupta, S.
Right arrow Articles by Hogan, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dasgupta, S.
Right arrow Articles by Hogan, E. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 43, 751-761, May 2002
Copyright © 2002 by Lipid Research, Inc.

3-O-acetyl-sphingosine-series myelin glycolipids

: characterization of novel 3-O-acetyl-sphingosine galactosylceramide

Somsankar Dasgupta1,*, Steven B. Levery{dagger} and Edward L. Hogan*

* Department of Neurology, Medical University of South Carolina, 96 Jonathan Lucas Street, P.O. Box 250606, Charleston, SC 29425
{dagger} Complex Carbohydrate Research Center and Department of Biochemistry and Molecular Biology, University of Georgia, 220 Riverbend Road, Athens, GA 30602

1 To whom correspondence should be addressed. e-mail: dasgupta{at}musc.edu

Several glycosphingolipids, less polar than galactosylceramide (GalCer), have been purified from rat brain and designated as fast migrating cerebrosides (FMCs). They co-appear with GalCer during myelinogenesis, reach a peak concentration at postnatal day 25–30 and are derivatives of GalCer. Extensive structural analysis of the partially methylated alditol acetates, mass-spectrometry, and 1H- and 13C-nuclear magnetic resonance (NMR) spectroscopy unequivocally established the structure of two of these FMCs as 3-O-acetyl-sphingosine GalCer with non-hydroxy and hydroxy fatty N-acylation respectively. That is, an acetyl group is linked at the C3-OH of the sphingosine base of GalCer. In addition, NMR spectroscopy of all of the purified FMCs indicates that they contain a 3-O-acetyl group linked with sphingosine and thus delineates a novel series. Several lines of evidence indicate that FMCs are myelin constituents. FMCs, enriched in both central nervous system (CNS) and peripheral nervous system (PNS) myelin, are concentrated in spinal cord and white matter that are composed of myelinated nerve fibers. There is N-acylation with {alpha}-hydroxy and C18 and C24 fatty acids, all characteristic of myelin components. They disappear along with GalCer in the murine genetic dysmyelinating disorders, jimpy and quaking, and in a knockout mutant which is devoid of GalCer. In addition, a decrease in FMC and GalCer concentration has been found in Krabbé's disease, a human genetic dysmyelinating disorder.—Dasgupta, S., S. B. Levery, and E. L. Hogan. 3-O-acetyl-sphingosine-series myelin glycolipids: characterization of novel 3-O-acetyl-sphingosine galactosylceramide. J. Lipid Res. 2002. 43: 751–761.

Abbreviations: dqCOSY, double quantum filtered correlation spectroscopy; ESI-MS, electrospray ionization mass spectrometry; FMC, fast migrating cerebroside; GalCer, Galß1-1Cer; GlcCer, Glcß1-1Cer; GM4, NeuAc{alpha}2-3GalCer; GC-MS, gas chromatography mass spectrometry; GSL, glycosphingolipid; gHMBC, gradient heteronuclear multiple bond correlation; gHSQC, gradient heteronuclear single quantum correlation; HFA, hydroxy fatty acid; jp, jimpy; KO, knockout; NFA, non-hydroxy fatty acid; PMAA, partially methylated alditol acetate; qk, quaking; sulfatide, I3-sulfate GalCer; TMS, tetramethylsilane; TOCSY, total correlation spectroscopy

Supplementary key words dysmyelinating disorder • mass spectrometry • monoglycosylceramide • nuclear magnetic resonance spectroscopy • vertebrate brain


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
J. Bodennec, D. Pelled, and A. H. Futerman
Aminopropyl solid phase extraction and 2 D TLC of neutral glycosphingolipids and neutral lysoglycosphingolipids
J. Lipid Res., January 1, 2003; 44(1): 218 - 226.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.